Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2016

View Archived Issues

Merck & Co. acquires IOmet

HemoShear and Pfizer advance collaboration in drug-induced vascular injury

Novel FXR agonist demonstrates preclinical efficacy for dyslipidemia

Takeda and NsGene partner to develop cell encapsulation therapies for Parkinson's disease

Medifocus engages Kapec Design Group as lead designer of next generation of Prolieve

Leech saliva extract shows promising preclinical results for prostate cancer

FDA grants orphan drug designation to FPA-008 for pigmented villonodular synovitis

Eagle Pharmaceuticals and AMRI to jointly develop and manufacture parenteral drugs

SNPs associated to androgen deprivation therapy response in aHSPC

Boehringer Ingelheim and Arena Pharmaceuticals collaborate on psychiatric diseases research

Strategic alliances for the development of novel therapeutics for gastrointestinal diseases

GTx initiates phase II trial of enobosarm for stress urinary incontinence

New collaborations in precision medicine

SNPs in SULT1E1 show potential as predictive biomarkers of response to abiraterone acetate in mCRPC

Cepheid to collaborate with MedImmune and COMBACTE to develop bacterial pneumonia diagnostics

FDA accepts IND application for Tricida's TRC-101

DelMar Pharmaceuticals and MD Anderson to collaborate in the development of VAL-083

Sucampo and CPP sign an agreement for late-stage development of CPP-1X/sulindac

Celgene describes KDM1A inhibitors

Istituto Europeo di Oncologia reports TTK inhibitors

Kyoto University, National Hospital Organization, and Nihon Medi-Physics present CYP11B2 inhibitors

Taiho Pharmaceutical introduces NEDD8-activating enzyme inhibitors

Shionogi patents TRPV4 antagonists

Spectrum Pharmaceuticals and Servier Canada enter a strategic partnership

Adimab and Merck & Co. enter a technology transfer agreement

LeafBio initiates phase I trial of MB-66 monoclonal antibody vaginal film

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...